Mechanistically, cisplatin-treated ovarian cancer cells induced the formation of myeloid-derived suppressor cells (MDSCs), which inhibited the cytotoxicity of CD8<sup>+</sup>T cells. The gene discussed is CD8A; the disease is ovarian carcinoma.